According to a recent report from McKinsey, 50 percent of registration trials fail. However, a systematic portfolio analysis by Eli Lilly found that improving the probability of technical success for clinical trials substantially improves R&D. The Center for Translational Medicine (CTM) is committed to just that – doubling R&D productivity.
Quantitative translational medicine, such as that found at CTM, integrates information from discovery to post-marketing using innovative quantitative tools. At CTM, we develope future scientific leaders, teaming up with pharmaceutical companies on their drug development strategies, offering pharmacometrics consulting services, and performing innovative research in quantitative translational modeling.
The CTM's experienced faculty and staff offer a variety of high-quality and timely services focused upon strategic decision-making that will cut your drug development time in half. The Center recognizes and commits to on-time project delivery and with the highest quality. We have a state-of-the art computational infrastructure, including Windows Servers, widely used pharmacometrics and statistical software packages, such as Pharsight Phoenix suite, WinNonLin, NONMEM, SAS, and R.